Canada becomes 2nd country to fully legalize

New Post Public Reply Private Reply Replies (0) Message Board
adirondackhi
923

Canada becomes 2nd country to fully legalize marijuana

Canadian lawmakers approved landmark legislation on Tuesday to fully legalize marijuana.

The move will make Canada the second country in the world to legalize cannabis for both medical and recreational purposes nationwide. Uruguay was the first to fully legalize the drug.

Bill C-45, also known as the Cannabis Act, was first introduced on April 13, 2017, in a bid to legalize and regulate the recreational use of weed. The bill passed in the House of Commons that November and then passed in the Senate on Tuesday night by a vote of 52-29, with two abstentions.

Medicinal use of the drug has been legal in Canada since 2001.

The proposed legislation allows adults in Canada to legally possess and use up to 30 grams of dried cannabis in public, as well as cultivate up to four cannabis plants at home and prepare products for personal use. Dried cannabis and cannabis oil will become commercially available later this year.

The minimum legal age to buy and consume pot in Canada will be set at 18, but the bill allows provinces and territories to increase the minimum age.


Canadian Justice Minister Jody Wilson-Raybould, who sponsored the legislation, called the bill's passage a "historic milestone."

"This is an historic milestone for progressive policy in Canada as we shift our approach to cannabis," Wilson-Raybould said via Twitter Tuesday night. "This legislation will help protect our youth from the risks of cannabis while keeping profits out of the hands of criminals and organized crime."

The federal law fulfills a top campaign promise of Canadian Prime Minister Justin Trudeau and his Liberal Party.

"It's been too easy for our kids to get marijuana -- and for criminals to reap the profits," Trudeau said via Twitter Tuesday night. "Today, we change that. Our plan to legalize [and] regulate marijuana just passed the Senate."
1

Rocky Mountain High Brands, Inc. (RMHB) Stock Research Links

RMHB Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Nvidia's Major $500 Million Investment in Wayve for AI Expansion

Updated Category News Views 206

Nvidia Invests $500 Million in Wayve Nvidia, known for its advanced AI technologies, is in discussions to invest a substantial $500 million into the U.K.-based autonomous driving startup Wayve. This move marks a significant step for Nvidia as it seeks to deepen its involvement in the rapidly evolving artificial intelligence sector. Strategic Importance of the Investment...

Continue Reading
Vortex Companies Enhances Leadership with Key Promotions

Updated Category News Views 164

Elevating Leadership at Vortex Companies Vortex Companies, known for its rapid growth in the trenchless infrastructure rehabilitation sector, has recently made significant leadership changes with the promotions of Jonathan Thomas and Connor Mathis. Thomas steps into the role of Senior Regional Vice President for the Coastal Region, while Mathis ascends to Regional Vice...

Continue Reading
Scilex Holding Company Receives FDA Acknowledgment for ELYXYB

Updated Category News Views 118

Scilex Holding Company’s FDA Milestone with ELYXYB Scilex Holding Company, based in Palo Alto, California, has gained significant recognition with the U.S. FDA's acknowledgment of their Supplemental New Drug Application (SNDA) for ELYXYB. This marks a substantial step forward for the company, which is dedicated to creating and advancing non-opioid pain management...

Continue Reading
Bio-Techne Expands AI-Driven Protein Portfolio

Updated Category News Views 8

Advanced Proteins in the Spotlight Bio-Techne’s latest move is creating some serious buzz in the life sciences scene. They're not just talking the talk but walking the walk by expanding their R&D Systems AI-Engineered Designer Protein portfolio. What's the big news? They've engineered heat-stable and hyperactive proteins that promise to shake up fibroblast growth factor...

Continue Reading
PolyPid's D-PLEX100 Trial Results Revolutionize Infection Prevention

Updated Category News Views 146

Groundbreaking Advances in Surgical Infection Prevention PolyPid Ltd. has made headlines recently, unveiling remarkable topline results from their pivotal SHIELD II Phase 3 trial. This innovative study showcased D-PLEX100, a major breakthrough in preventing surgical site infections (SSIs), showing statistically significant reductions in both primary and secondary...

Continue Reading